Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases

OBJECTIVE: Idiopathic thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder mediated by autoantibodies directed against ADAMTS13. This provides a rationale for the use of rituximab in this disorder. We report our experience and the outcome of 10 cases of TTP (9 refractory and 1 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Omri, Halima El, Taha, Ruba Y, Gamil, Amna, Ibrahim, Firyal, Sabah, Hisham Al, Mahmoud, Zeinab O, Pittari, Gianfranco, HIjji, Ibrahim Al, Yassin, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451552/
https://www.ncbi.nlm.nih.gov/pubmed/26052230
http://dx.doi.org/10.4137/CMBD.S25326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451552/
https://www.ncbi.nlm.nih.gov/pubmed/26052230
http://dx.doi.org/10.4137/CMBD.S25326

Ejemplares similares